Tectonic Therapeutic (TECX) Research & Development (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Research & Development of $20.9 million for Q1 2026, up 60.1% year-over-year from $13.0 million in Q1 2025, and up 27.72% quarter-over-quarter from $16.3 million in Q4 2025.
Tectonic Therapeutic (TECX) Research & Development (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Research & Development for 10 consecutive years, with $20.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 60.1% year-over-year to $20.9 million; the TTM figure through Mar 2026 stood at $71.3 million (up 63.65% YoY), while the FY2025 annual figure was $63.5 million, up 53.49% from the prior year.
- Research & Development rose to $20.9 million in Q1 2026 per TECX's latest filing, from $16.3 million in the prior quarter.
- Across five years, Research & Development topped out at $20.9 million in Q1 2026 and bottomed at $7.1 million in Q2 2024.
- Historically, Research & Development has averaged $14.1 million across 5 years, with a median of $15.9 million in 2022.
- Annual changes were most pronounced in 2023 — Research & Development tumbled 60.35% — and 2025, when it jumped 142.93%.
- Tectonic Therapeutic's Research & Development stood at $18.1 million in 2022, then sank by 60.35% to $7.2 million in 2023, then gained by 27.31% to $9.2 million in 2024, then surged by 78.47% to $16.3 million in 2025, then advanced by 27.72% to $20.9 million in 2026.
- Business Quant data shows TECX's Research & Development at $20.9 million in Q1 2026, $16.3 million in Q4 2025, and $16.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.05 Mn |
| Mar 31, 2026 | 20.87 Mn |
| Dec 31, 2025 | 16.34 Mn |
| Sep 30, 2025 | 16.93 Mn |
| Jun 30, 2025 | 17.19 Mn |
| Mar 31, 2025 | 13.04 Mn |
| Dec 31, 2024 | 9.16 Mn |
| Sep 30, 2024 | 14.32 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Mar 31, 2024 | 10.82 Mn |
| Dec 31, 2023 | 7.19 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 8.77 Mn |
| Mar 31, 2023 | 17.33 Mn |
| Dec 31, 2022 | 18.14 Mn |
| Sep 30, 2022 | 15.92 Mn |
| Jun 30, 2022 | 18.88 Mn |
| Mar 31, 2022 | 19.25 Mn |
| Dec 31, 2021 | 19.00 Mn |
| Sep 30, 2021 | 23.04 Mn |